March 13, 2018 | Denise Heady
Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.
CAR T Laboratory Research Yields Promising Prostate Cancer Results
April 17, 2018 | Letisia Marquez
City of Hope physicians have successfully treated blood cancers with chimeric antigen receptor (CAR) T cell therapy, and they are working to expand that therapy to patients with prostate cancer and other solid tumors.
Meet our doctors: How Leo Wang is revolutionizing the way that pediatric and blood cancers are treated
March 17, 2017 | Denise Heady
Dual-trained pediatric oncologist and scientist Leo Wang, M.D., Ph.D., is working in the lab to understand how blood cells develop and grow, and plans to use that information to help patients with cancer live longer and experience fewer side effects of treatment.
Blood cancers: The basics you should know
April 8, 2016 | Denise Heady
On a recent segment of “KTLA 5 morning news,” City of Hope neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., discussed how City of Hope is pioneering the treatment of blood cancers through bone marrow transplantation.
The promise of a more durable treatment for recurrent blood cancers
December 6, 2015 | Elise Lamar
Cancer researchers increasingly realize that drug combinations, as opposed to single drugs, may be the best treatment approach. If so, some are asking, why not entirely different treatment regimens to create the ultimate weapon against tumors? City of Hope researchers are addressing that possibility by combining two approaches at which they excel.
Cancer research 2015: T cell immunotherapy, targeted drugs and more
January 1, 2015 | Tami Dennis
Every year, researchers make gains in the understanding of cancer, and physicians make gains in the treatment of cancer. As a result, every year, more cancer patients survive their disease. In 2015, cancer research will move forward in ways both high-profile and little-heralded.
Stem cell transplants OK for HIV-linked lymphoma patients, study finds
December 8, 2014 | Nicole White
Patients with HIV-associated lymphoma may soon have increased access to the current standard of care for some non-HIV infected patients – autologous stem cell transplants. City of Hope's Joseph Alvarnas shares results from a City of Hope study at the annual ASH meeting that supports change to standard of care for HIV lymphoma.
For bone marrow transplant patients, outcomes and data matter
August 22, 2014 | Nicole White
Nearly four decades ago, City of Hope began its bone marrow transplant program. Its first transplant reunion celebration was a single patient and his donor, also his brother. City of Hope has performed nearly 12,000 hematopoietic cell transplants, and has the best outcomes in the nation.
This celebration (Bone Marrow Transplant Reunion) includes reflection
May 7, 2014 | Nicole White
At City of Hope's upcoming Bone Marrow Transplant Reunion on Friday, May 9, hundreds of patients and the doctors and nurses who cared for them through their battles with cancer and other hematologic diseases will celebrate life and second chances.